V015-2265 Screening compound: ethyl 5-(4-{4-[2-(acetyloxy)-2-methylpropanoyl]piperazin-1-yl}phenyl)-1-(pyridin-2-yl)-1H-pyrazole-3-carboxylate

V015-2265 Screening compound: ethyl 5-(4-{4-[2-(acetyloxy)-2-methylpropanoyl]piperazin-1-yl}phenyl)-1-(pyridin-2-yl)-1H-pyrazole-3-carboxylate
V015-2265 Screening compound: ethyl 5-(4-{4-[2-(acetyloxy)-2-methylpropanoyl]piperazin-1-yl}phenyl)-1-(pyridin-2-yl)-1H-pyrazole-3-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-2265
ethyl 5-(4-{4-[2-(acetyloxy)-2-methylpropanoyl]piperazin-1-yl}phenyl)-1-(pyridin-2-yl)-1H-pyrazole-3-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-2265

Molecular Formula

C27H31N5O5 (C27 H31 N5 O5)

Compound Name

ethyl 5-(4-{4-[2-(acetyloxy)-2-methylpropanoyl]piperazin-1-yl}phenyl)-1-(pyridin-2-yl)-1H-pyrazole-3-carboxylate

IUPAC name

ethyl 5-(4-{4-[2-(acetyloxy)-2-methylpropanoyl]piperazin-1-yl}phenyl)-1-(pyridin-2-yl)-1H-pyrazole-3-carboxylate

SMILES

CCOC(c(cc1-c(cc2)ccc2N(CC2)CCN2C(C(C)(C)OC(C)=O)=O)nn1-c1ncccc1)=O

InChI

InChI=1S/C27H31N5O5/c1-5-36-25(34)22-18-23(32(29-22)24-8-6-7-13-28-24)20-9-11-21(12-10-20)30-14-16-31(17-15-30)26(35)27(3,4)37-19(2)33/h6-13,18H,5,14-17H2,1-4H3

InChI Key

BKFKMGRHIVJKRF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19946847

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

505.57

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.471

Distribution Coefficient, logD

3.471

Water Solubility, LogSw

-3.60

Polar Surface Area

82.458

Acid Dissociation Constant (pKa)

24.82

Base Dissociation Constant (pKb)

2.98

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.00

V015-2265 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V015-2265 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-2265?
Check Price and Availability of V015-2265, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-2265 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-2265
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-2265
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-2265 available by request